Nippon India Pharma Fund-Growth Plan-Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 509.1637 ↓ -0.26%
[as on 26 December, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund-Growth Plan-Growth Option -3.82% -0.26% -0.19% -1.85% 2.22% -1.25% 21.55% 15.03% 19.42% 13.05%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.67% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.33%

Equity

NameSymbol / ISINSectorWeight %QuantityQty change %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.67%6256349-
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.07%1000031-
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology7.26%3083991-
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology6.29%3495054-
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.97%648795-
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.62%3916074-
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.42%2886684-
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.32%3627277-
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology3.05%1320549-
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.87%913226-
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology2.83%959323-
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.81%2555745-
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.59%1548692-1.53%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.39%68677-
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.32%1702630-
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.29%609112-
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.16%757496-
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.14%323678-
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology2.10%4719374-
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.01%999649-
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.99%318249-
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.95%923911-10.23%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.50%984838+20.10%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.48%3896349-
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.35%1103889-
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology1.32%230272-
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.24%213659-
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services1.23%891340-
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services1.00%1280492-
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.90%1058503-
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.84%1515264-
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology0.74%470272-
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.72%62568-
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.61%1834924-
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology0.43%492727-
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.19%111738-
Portfolio data is as on date 31 October, 2025

NAV (Net asset value) history

Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV history

DateNAV
26 December, 2025509.1637
24 December, 2025510.4706
23 December, 2025511.8011
22 December, 2025513.2988
19 December, 2025510.1223
18 December, 2025506.1386
17 December, 2025507.0130
16 December, 2025508.7742
15 December, 2025511.0063
12 December, 2025512.6218
11 December, 2025512.1817
10 December, 2025507.8291
9 December, 2025508.2588
8 December, 2025509.7895
5 December, 2025515.1984
4 December, 2025516.9317
3 December, 2025514.4509
2 December, 2025515.4743
1 December, 2025516.2471
28 November, 2025520.0092
27 November, 2025517.5324
26 November, 2025518.7420
25 November, 2025514.7720
24 November, 2025513.4441
21 November, 2025515.3218
20 November, 2025517.4179
19 November, 2025518.5172
18 November, 2025517.7567
17 November, 2025521.1516
14 November, 2025519.1691

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 509.1637 as on 26 December, 2025.
  • What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are -3.82% as on 26 December, 2025.
  • What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are -1.25% as on 26 December, 2025.
  • What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 21.55% as on 26 December, 2025.
  • What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 15.03% as on 26 December, 2025.
  • What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 15.03% as on 26 December, 2025.